Behavioral Clinical Research, Inc. — research payments reported

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$692	1
2023	Research	$822	2
2021	Research	$81	1
2020	Research	$8	2
2019	Research	$84,235	55

Breakdown

Who paid Research payments · program years 2019–2025

Alkermes, Inc. $84,323 58 payments
Neurocrine Biosciences, Inc. $822 2 payments
E.R. Squibb & Sons, L.L.C. $692 1 payment

Studies the money was for Research payments · program years 2019–2025

A Phase 3 Study to Evaluate Weight Gain of ALKS 3831 Compared to OLANZAPINE in Adults with Schizophrenia $41,192 4 payments
A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia $32,855 15 payments
A Phase 3b Efficacy and Safety Study of Adjunctive ALKS 5461 in Treatment Refractory Major Depressive Disorder $6,567 30 payments
A Phase 3b Extension Study of Adjunctive ALKS5461 in the Treatment of Refractory Major DepressiveDisorder $2,250 2 payments
Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 $1,000 1 payment
A Phase 4, Single-Arm, Open-Label Study to Evaluate the Effectiveness of Valbenazine on Patient- and Clinician-Reported Outcomes in Subjects With Tardive Dyskinesia $822 2 payments
A Study to Assess Efficacy and Safety of Adjunctive KarXT in Subjects With Inadequately Controlled Symptoms of Schizophrenia (ARISE) $692 1 payment
A Phase 3, Multicenter Study to Assess the Long Term Safety and Tolerability of ALKS 3831 in Subjects with Schizophrenia $378 5 payments
A Phase 3 Study to Assess the Long Term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831 in Subjects With Schizophrenia, Schizophreniform Disorder, or Bipolar I Disorder $81 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.